SBI Securities’s Celularity CELU Stock Holding History

SBI Securities’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.54K	Sell	1,882 -402	-18%	-$408	﹤0.01%	2498
2026 Q2	$1.37K	Buy	2,284 +461	+25%	+$442	﹤0.01%	2690
2026 Q1	$2.42K	Sell	1,823 -45	-2%	-$57	﹤0.01%	2353
2025 Q4	$2.07K	Sell	1,868 -5,286	-74%	-$9.48K	﹤0.01%	2363
2025 Q3	$14.8K	Sell	7,154 -1,682	-19%	-$4.71K	﹤0.01%	1578
2025 Q2	$17.3K	Sell	8,836 -3,285	-27%	-$5.98K	﹤0.01%	1472
2025 Q1	$21K	Buy	12,121 +11,793	+3,595%	+$22.3K	﹤0.01%	1310
2024 Q4	$682	Buy	+328	New	+$783	﹤0.01%	2773

Other funds holding CELU

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

SBI Securities's CELU Position: Q3 2026 in Review

SBI Securities reduced its Celularity (CELU) stake by 18% in Q3 2026, selling an estimated $408 and leaving 1,882 shares worth $2.54K. The position accounts for ﹤0.01% of the portfolio, ranked #2498.

SBI Securities first reported a position in CELU in Q4 2024 and has held it in 8 quarters since. The position peaked at $21K in Q1 2025. 2 funds tracked by Wall St. Rank hold CELU as of Q3 2026.

SBI Securities held 1,882 shares of Celularity worth $2.54K as of Q3 2026.
SBI Securities sold 402 Celularity shares in Q3 2026, an estimated $408.
Celularity made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #2498 holding.
SBI Securities first reported a position in Celularity in Q4 2024 and has held it in 8 quarters since.
SBI Securities's Celularity position peaked at $21K in Q1 2025.
2 funds tracked by Wall St. Rank held Celularity as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.